Browse the corpus

Ventricular tachycardia (VT) is characterized by an abnormal electrical focus, or circuit, within the ventricular myocardium. VT often presents with a rapid ventricular rate and a wide QRS complex on an electrocardiogram, hindering the ability of the heart to maintain an adequate cardiac output and a proper coronary flow, which may lead to symptoms such as dizziness, syncope, or even sudden cardiac death depending on the rate and duration of the arrhythmia. VT treatment options include antiarrhythmic medications, catheter ablation, and implantable cardiac defibrillators (ICDs). Antiarrhythmic medications can reduce an arrhythmia's recurrence but carry adverse events and risks, making catheter ablation a potentially definitive treatment if the arrhythmic focus or circuit is accurately identified and ablated.[1] The success of VT ablation varies with the underlying condition and operator skills, reaching above 90%—with the highest success rate in patients with normal hearts. Success rates in patients with scar or cardiomyopathy range between 50% to 75% at 6 to 12 months, and if there is a recurrence, 66% of patients will have less frequent VT than before ablation. While ICDs provide critical emergency treatment, they do not prevent arrhythmia initiation and are thus used for arrhythmias that have proven to be resistant to ablation and medication.[2]

VT ablation can be particularly challenging in patients with advanced cardiovascular disease. Despite its potential benefits, the procedure carries a significant risk of serious complications. The overall rate of major complications ranges from 8% to 10%, highlighting the critical need for careful patient assessment and procedural planning.[36][37] Major Complications Stroke The manipulation of catheters, especially within the left heart, can lead to thromboembolism. This risk arises from the potential dislodgement of thrombi or emboli, which can subsequently travel to the brain and cause a stroke. The use of anticoagulants during the procedure further complicates this risk. Valvular injury Catheter movement and ablation near heart valves may damage these structures, potentially leading to valvular insufficiency or stenosis. This injury can result from direct mechanical trauma or thermal effects of the ablation. Major bleeding The procedure’s demands for vascular access and anticoagulation increase the risk of significant bleeding. This may manifest as local bleeding, hematoma, AV fistula, pseudoaneurysm, or major vessel perforation. Such complications might require transfusions or even surgical intervention. Cardiac tamponade A rare but critical complication, cardiac tamponade occurs when fluid accumulates in the pericardial space, compressing the heart and impairing its function. This condition necessitates immediate emergent management. Hemodynamic collapse Severe arrhythmias or procedural complications can lead to abrupt cardiovascular instability. Hemodynamic collapse may necessitate urgent resuscitation and intensive care. Death As reported in several trials, the periprocedural mortality rate for recurrent VT ablation is around 2.7% to 3%. This underscores the inherent risks associated with the procedure, especially in patients with severe underlying conditions. Additional Considerations Allergic reactions Reactions to contrast agents, anesthetics, antibiotics, and other medications used during the procedure can pose significant risks. Skin injuries Injuries related to cardioversion or radiation/fluoroscopy exposure can occur, necessitating careful monitoring and preventive measures.

Effective management of ventricular tachycardia through electrophysiology study and ablation demands a highly coordinated interprofessional approach. Clinicians, particularly electrophysiologists, lead the diagnostic and therapeutic process by interpreting complex arrhythmic patterns and guiding catheter-based interventions. Advanced clinicians and nurses are crucial in preparing patients for the procedure, monitoring their status, and managing immediate postprocedural care. They ensure that patients are well-informed and comfortable, promptly addressing concerns or complications. Pharmacists contribute by managing and reviewing medications, particularly anticoagulants and antiarrhythmics, to minimize adverse effects and optimize therapeutic outcomes. Interprofessional communication is essential for seamless care coordination. Regular briefings among team members before, during, and after the procedure ensure that all aspects of patient management are addressed, from preprocedural preparations to postoperative monitoring and follow-up. Collaboration in these stages helps in early identification and mitigation of potential complications, enhancing patient safety. Additionally, effective care coordination extends to educating patients about their condition and treatment options, which fosters adherence to postprocedural care plans and contributes to better long-term outcomes. By leveraging the combined expertise of the entire healthcare team, patient-centered care is improved, outcomes are optimized, and the risk of procedural complications is reduced.